Biofrontera Inc. (NASDAQ:BFRI) Sees Significant Drop in Short Interest

Biofrontera Inc. (NASDAQ:BFRI) was the recipient of a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 292,400 shares, a decline of 44.9% from the December 15th total of 530,600 shares. Currently, 4.7% of the shares of the stock are sold short. Based on an average trading volume of 3,010,000 shares, the short-interest ratio is currently 0.1 days.

Biofrontera Stock Performance

Shares of NASDAQ:BFRI traded down $0.05 during midday trading on Wednesday, hitting $1.00. The company’s stock had a trading volume of 231,062 shares, compared to its average volume of 1,838,854. Biofrontera has a 12-month low of $0.61 and a 12-month high of $2.43. The company has a market cap of $7.75 million, a P/E ratio of -0.44 and a beta of 0.27. The business’s 50 day simple moving average is $0.99 and its 200 day simple moving average is $1.05.

Analyst Upgrades and Downgrades

Separately, Benchmark reissued a “buy” rating and issued a $7.00 price objective on shares of Biofrontera in a research note on Friday, November 15th.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.